One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
  • inquiry@market.us
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
Home » Companies » Bruker Corp. Company Profile

Bruker Corp. Company Profile

logo

Bruker Corp

Manufacturing

  • Type

    Public

  • Headquarters

    The US

  • Founded

    1960

  • Key Management

    Mr.Frank H Laukien CEO)

  • Revenue

    ~2,417.9(2021)

  • Headcount

    ~7,765(2021)

  • Website

    www.bruker.com

Business Description

Bruker Corp. develops, manufactures, and distributes scientific instruments and analytical and diagnostic tools that allow customers to examine life and materials at the microscopic, molecular, and cellular levels. It is represented by the Bruker Scientific Instruments, Bruker Energy, and Supercon Technologies segments. The Bruker BioSpin Group and the Bruker CALID Group make up the BSI segment. The BEST segment manufactures and distributes superconducting materials. These include metallic low-temperature superconductors for magnetic resonance imaging, nuclear magnetic resonance, and other applications. Gunther Laukien founded the company in 1961. It is based in Billerica MA.

 

Key Financials

 

Revenue (US$ Mn):

 

  • US$ 2,418 Mn was the annual revenue generated by Bruker Corp. in 2021
  • Bruker Corp.’s annual revenue for 2020 was US$ 1,988 Mn, a -4.11% decrease from 2019
  • From 2018’s annual revenues, Bruker Corp. registered a 9.34% increase in 2019, amounting to US$ 2,073 Mn
  • Total revenue of US$ 1,896 Mn was generated in 2018 by Bruker Corp.

 

Operating Income (US$ Mn):

 

  • Bruker Corp.’s operating income for 2021 was US$ 413 Mn, a 66.45% increase from 2020
  • The operating income generated by Bruker Corp. in 2020 was US$ 248 Mn
  • At a 14.67% increase, Bruker Corp.’s operating income of US$ 301 Mn was indexed in 2019
  • Bruker Corp. generated an operating income of US$ 262 Mn in 2018

 

Net Income (US$ Mn):

 

  • Bruker Corp.’s net income for 2021 was US$ 281 Mn, a 73.85% increase from 2020
  • The net income generated by Bruker Corp. in 2020 was US$ 161 Mn
  • At a 9.74% increase, Bruker Corp.’s net income of US$ 197 Mn was indexed in 2019
  • Bruker Corp. generated a net income of US$ 180 Mn in 2018

 

Operating Margin %:

 

  • Bruker Corp.’s operating margin for 2021 was 17%, a 37.1% increase from 2020
  • The operating margin generated by Bruker Corp. in 2020 was 12%
  • At a 1.41% increase, Bruker Corp.’s operating margin of 14% was indexed in 2019
  • Bruker Corp. generated an operating margin of 14% in 2018

 

Gross Margin %:

 

  • Bruker Corp.’s gross margin for 2021 was 12%, a 42.86% increase from 2020
  • The gross margin generated by Bruker Corp. in 2020 was 8%
  • At a 1.06% increase, Bruker Corp.’s gross margin of 10% was indexed in 2019
  • Bruker Corp. generated a gross margin of 9% in 2018

 

SWOT Analysis

 

Strengths

Customer Base

Bruker’s diverse customer base helps to improve its market position. The Scientific Instruments segment’s customers include pharmaceutical, biotechnology, diagnostics, and contract research organizations, academic institutions, and medical schools. Customers include semiconductor and nanotechnology companies as well as raw material manufacturers and industrial companies. Bruker Energy and Supercon Technologies segments’ customers include pharmaceutical companies, public and private research and development laboratories in fundamental and energy research, academic institutions, and government agencies. A diverse customer base reduces Bruker’s exposure to risks associated with a specific customer segment.

 

 

Get this premium content

The Premium data is Locked
Buy Now to Unlock Premium Data

Table of Content

  1. Business Description
  2. Key Financials
  3. SWOT Analysis
    1. Strength
      1. Customer Base
      2. Territorial Diversity
      3. Innovation
      4. Revenue Growth
    2. Weaknesses
      1. Dependence on Few Suppliers and Contract Manufacturers
    3. Opportunities
      1. Global Pharmaceutical Industry
    4. Threats
      1. Foreign Exchange Risks
      2. Intense Competition
      3. Conflict Minerals Regulations
    5. Key Developments
      1. Year 2020
      2. Year 2019
      3. Year 2018
  • US $299
  • US $499
Buy Now
✖

Request For Company Data

We'll get back to you as quickly as possible

Primary Sidebar

  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
auto undefined
af Afrikaanssq Albanianam Amharicar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbn Bengalibs Bosnianbg Bulgarianca Catalanceb Cebuanony Chichewazh-CN Chinese (Simplified)zh-TW Chinese (Traditional)co Corsicanhr Croatiancs Czechda Danishnl Dutchen Englisheo Esperantoet Estoniantl Filipinofi Finnishfr Frenchfy Frisiangl Galicianka Georgiande Germanel Greekgu Gujaratiht Haitian Creoleha Hausahaw Hawaiianiw Hebrewhi Hindihmn Hmonghu Hungarianis Icelandicig Igboid Indonesianga Irishit Italianja Japanesejw Javanesekn Kannadakk Kazakhkm Khmerko Koreanku Kurdish (Kurmanji)ky Kyrgyzlo Laola Latinlv Latvianlt Lithuanianlb Luxembourgishmk Macedonianmg Malagasyms Malayml Malayalammt Maltesemi Maorimr Marathimn Mongolianmy Myanmar (Burmese)ne Nepalino Norwegianps Pashtofa Persianpl Polishpt Portuguesepa Punjabiro Romanianru Russiansm Samoangd Scottish Gaelicsr Serbianst Sesothosn Shonasd Sindhisi Sinhalask Slovaksl Slovenianso Somalies Spanishsu Sundanesesw Swahilisv Swedishtg Tajikta Tamilte Teluguth Thaitr Turkishuk Ukrainianur Urduuz Uzbekvi Vietnamesecy Welshxh Xhosayi Yiddishyo Yorubazu Zulu
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library

© 2025 Market.Us. All Rights Reserved.